Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 131 Total
NISN - NiSun International Enterprise Development Group Co Ltd - Stock Price Chart
TickerNISN [NASD]
CompanyNiSun International Enterprise Development Group Co Ltd
CountryChina
IndustryCredit Services
Market Cap30.16MEPS (ttm)1.16
P/E6.50EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-2.04%
P/S0.12EPS next 5Y-
P/B1.57EPS Q/Q-91.92%
Dividend-Sales Q/Q7.49%
Insider Own24.22%Inst Own4.42%
Insider Trans0.00%Inst Trans-49.57%
Short Float0.48%Earnings-
Analyst Recom1.00Target Price91.00
Avg Volume104.99K52W Range2.16 - 8.85
Nisun International Enterprise Development Group Co., Ltd. engages in the development, manufacture, and provision of customized installation of valves and pipe fitting. Its products are used for pharmaceutical, biological, food and beverage, and other clean industries. The firm also offers steel fittings, sanitary pump, and filter. The company was founded on May 29, 2012 and is headquartered in Shanghai, China.
ASRV - Ameriserv Financial Inc - Stock Price Chart
TickerASRV [NASD]
CompanyAmeriserv Financial Inc
CountryUSA
IndustryBanks - Regional
Market Cap43.05MEPS (ttm)-0.17
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.55EPS next 5Y-
P/B0.41EPS Q/Q25.71%
Dividend4.78%Sales Q/Q5.43%
Insider Own19.53%Inst Own36.25%
Insider Trans0.32%Inst Trans-2.42%
Short Float0.16%Earnings-
Analyst Recom-Target Price-
Avg Volume19.39K52W Range2.25 - 3.40
AmeriServ Financial, Inc. is a holding company, which engages in the provision of consumer, mortgage and commercial financial products and services through its subsidiary. It operates through the following segments: Community Banking, Wealth Management, and Investment or Parent. The Community Banking segment includes both retail and commercial banking activities. The Wealth Management segment is involved in the operations of a Trust Company, West Chester Capital Advisors, an investment advisory firm, and Financial Services. The Investment or Parent segment offers investment securities, borrowing activities, and general corporate expenses. The company was founded in January 1983 and is headquartered in Johnstown, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STOPKO JEFFREY APresident & CEO ASRV & BankMar 12 '24Buy2.532,0005,060136,189Mar 13 09:45 AM
STOPKO JEFFREY APresident & CEO ASRV & BankFeb 27 '24Buy2.742,0005,480134,189Feb 28 10:34 AM
Bloomingdale Richard W.DirectorFeb 23 '24Buy2.851,7254,9169,919Feb 26 03:13 PM
STOPKO JEFFREY APresident & CEO ASRV & BankFeb 21 '24Buy2.942,0005,880132,189Feb 21 03:04 PM
STOPKO JEFFREY APresident & CEO ASRV & BankOct 31 '23Buy2.562,0005,120127,548Nov 01 01:43 PM
RENB - Renovaro Inc. - Stock Price Chart
TickerRENB [NASD]
CompanyRenovaro Inc.
CountryUSA
IndustryBiotechnology
Market Cap219.82MEPS (ttm)-0.65
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-19.64%
P/S-EPS next 5Y-
P/B2.36EPS Q/Q14.32%
Dividend-Sales Q/Q-
Insider Own28.97%Inst Own1.76%
Insider Trans0.00%Inst Trans-1.58%
Short Float2.16%Earnings-
Analyst Recom-Target Price-
Avg Volume311.95K52W Range0.39 - 5.25
Apr-24-24 09:00AM RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership (GlobeNewswire)
Apr-18-24 08:45AM Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care (GlobeNewswire)
Mar-04-24 09:00PM Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Chemours, Trupanion, and Renovaro and Encourages Investors to Contact the Firm (GlobeNewswire) +12.99%
Feb-15-24 09:25AM Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace (GlobeNewswire) -8.68%
Feb-14-24 10:01AM Statement of Renovaro Inc (GlobeNewswire) +14.06%
Feb-13-24 09:46AM Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace (GlobeNewswire) -42.86%
09:31AM AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine (GlobeNewswire)
Jan-25-24 12:45PM Renovaro Biosciences Announces Results of Special Meeting of Shareholders (GlobeNewswire) +7.38%
Jan-18-24 09:30AM Renovaro BioSciences Releases CEO Shareholder Message (NewMediaWire)
Jan-16-24 08:00AM Message from Renovaro Bioscience, Inc.'s CEO, The Hon. Mark Dybul, MD (GlobeNewswire)
Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.
IKT - Inhibikase Therapeutics Inc - Stock Price Chart
TickerIKT [NASD]
CompanyInhibikase Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap11.08MEPS (ttm)-3.62
P/E-EPS this Y51.12%
Forward P/E-EPS next Y32.95%
PEG-EPS past 5Y-23.31%
P/S42.62EPS next 5Y-
P/B0.96EPS Q/Q33.63%
Dividend-Sales Q/Q-100.00%
Insider Own14.50%Inst Own7.16%
Insider Trans0.00%Inst Trans-20.47%
Short Float0.98%EarningsMar 27/a
Analyst Recom1.00Target Price17.50
Avg Volume114.28K52W Range0.79 - 4.35
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in developing protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. It also focuses on neurodegeneration and its lead program IkT-148009, an Abelson Tyrosine Kinase (c-Abl) inhibitor, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Ableson Tyrosine Kinases. The company was founded by Milton H. Werner in September 2008 and is headquartered in Atlanta, GA.
DXCM - Dexcom Inc - Stock Price Chart
TickerDXCM [NASD, NDX, S&P 500]
CompanyDexcom Inc
CountryUSA
IndustryMedical Devices
Market Cap49.24BEPS (ttm)1.55
P/E80.27EPS this Y17.35%
Forward P/E55.10EPS next Y26.51%
PEG2.40EPS past 5Y-
P/S12.95EPS next 5Y33.40%
P/B21.92EPS Q/Q198.58%
Dividend-Sales Q/Q24.21%
Insider Own2.10%Inst Own96.71%
Insider Trans-3.29%Inst Trans-0.36%
Short Float3.04%EarningsApr 25/a
Analyst Recom1.32Target Price151.03
Avg Volume3.10M52W Range74.75 - 142.00
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dolan Matthew VincentEVP Strategy and Corporate DevApr 15 '24Sale137.811,990274,24242,377Apr 16 04:16 PM
SAYER KEVIN RPresident CEO and ChairmanApr 08 '24Sale138.3049,6336,864,136283,893Apr 10 04:04 PM
Brown Michael JonEVP Chief Legal OfficerMar 28 '24Sale140.042,624367,47268,682Mar 29 07:30 PM
Stern SadieEVP Chief Human ResourcesMar 25 '24Sale140.004,137579,18076,304Mar 26 04:46 PM
Dolan Matthew VincentEVP Strategy & Corp DevMar 15 '24Sale130.214,203547,25944,367Mar 19 04:55 PM
LUXH - LuxUrban Hotels Inc - Stock Price Chart
TickerLUXH [NASD]
CompanyLuxUrban Hotels Inc
CountryUSA
IndustryLodging
Market Cap43.06MEPS (ttm)-2.15
P/E-EPS this Y834.21%
Forward P/E3.32EPS next Y210.00%
PEG-EPS past 5Y-227.20%
P/S0.38EPS next 5Y30.00%
P/B-EPS Q/Q-356.48%
Dividend-Sales Q/Q112.47%
Insider Own75.61%Inst Own15.77%
Insider Trans-0.18%Inst Trans157.88%
Short Float24.98%EarningsApr 15/b
Analyst Recom1.00Target Price5.00
Avg Volume472.41K52W Range0.73 - 6.88
LuxUrban Hotels Inc. engages in the acquisition and management of hotel units. The company was founded on December 13, 2019 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ferdinand BrianChairman & Co-CEODec 13 '23Buy4.5625,000114,050225,825Dec 14 08:30 AM
Ferdinand BrianChairman & Co-CEODec 01 '23Sale4.4514,21963,27515,347,917Dec 04 07:00 AM
Ferdinand BrianChairman & Co-CEONov 30 '23Sale4.4662,000276,52015,362,136Dec 04 07:00 AM
Ferdinand BrianChairman & Co-CEONov 22 '23Sale5.216,55634,15715,424,136Nov 24 05:13 PM
Ferdinand BrianChairman & Co-CEONov 21 '23Sale5.1038,277195,21315,430,692Nov 24 05:13 PM
CABA - Cabaletta Bio Inc - Stock Price Chart
TickerCABA [NASD, RUT]
CompanyCabaletta Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap515.27MEPS (ttm)-1.66
P/E-EPS this Y-15.09%
Forward P/E-EPS next Y-10.08%
PEG-EPS past 5Y-26.63%
P/S-EPS next 5Y-
P/B2.23EPS Q/Q11.80%
Dividend-Sales Q/Q-
Insider Own18.86%Inst Own88.40%
Insider Trans-0.37%Inst Trans-19.26%
Short Float26.00%EarningsMar 21/b
Analyst Recom1.00Target Price34.11
Avg Volume989.83K52W Range7.77 - 26.35
Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Binder GwendolynSee RemarksJan 19 '24Option Exercise1.0111,00011,11031,000Jan 19 06:30 PM
Binder GwendolynSee RemarksJan 19 '24Sale19.5911,000215,43920,000Jan 19 06:30 PM
Binder GwendolynSee RemarksDec 19 '23Option Exercise1.0111,00011,11031,000Dec 19 08:37 PM
Binder GwendolynSee RemarksDec 19 '23Sale21.8911,000240,78920,000Dec 19 08:37 PM
Binder GwendolynSee RemarksNov 20 '23Option Exercise1.0111,00011,11031,000Nov 21 04:30 PM
TEAM - Atlassian Corporation - Stock Price Chart
TickerTEAM [NASD, NDX]
CompanyAtlassian Corporation
CountryUSA
IndustrySoftware - Application
Market Cap46.55BEPS (ttm)-0.63
P/E-EPS this Y47.50%
Forward P/E56.45EPS next Y12.26%
PEG-EPS past 5Y-31.08%
P/S11.17EPS next 5Y23.70%
P/B51.44EPS Q/Q105.98%
Dividend-Sales Q/Q29.90%
Insider Own40.12%Inst Own53.95%
Insider Trans-2.01%Inst Trans-4.56%
Short Float2.83%EarningsApr 25/a
Analyst Recom2.03Target Price244.65
Avg Volume1.77M52W Range128.02 - 258.69
Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its software helps teams organize, discuss, and complete shared work. Its products include Jira Software, Confluence, Jira Service Management, and Trello. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cannon-Brookes MichaelCo-CEO, Co-FounderApr 25 '24Sale197.538,2411,627,835358,209Apr 26 05:59 PM
Farquhar ScottCo-CEO, Co-FounderApr 25 '24Sale197.538,2411,627,835358,209Apr 26 05:59 PM
Cannon-Brookes MichaelCo-CEO, Co-FounderApr 24 '24Sale199.718,2411,645,777366,450Apr 25 05:06 PM
Farquhar ScottCo-CEO, Co-FounderApr 24 '24Sale199.718,2411,645,776366,450Apr 25 05:20 PM
Cannon-Brookes MichaelCo-CEO, Co-FounderApr 23 '24Sale199.618,2411,645,001374,691Apr 24 05:54 PM
AEMD - Aethlon Medical Inc - Stock Price Chart
TickerAEMD [NASD]
CompanyAethlon Medical Inc
CountryUSA
IndustryMedical Devices
Market Cap3.56MEPS (ttm)-5.02
P/E-EPS this Y11.53%
Forward P/E-EPS next Y49.62%
PEG-EPS past 5Y38.94%
P/S6.25EPS next 5Y-
P/B0.46EPS Q/Q-10.91%
Dividend-Sales Q/Q-
Insider Own13.01%Inst Own1.98%
Insider Trans0.00%Inst Trans-
Short Float1.31%EarningsFeb 14/a
Analyst Recom2.00Target Price23.00
Avg Volume8.18K52W Range1.35 - 5.00
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.
NXTT - Next Technology Holding Inc. - Stock Price Chart
TickerNXTT [NASD]
CompanyNext Technology Holding Inc.
CountryChina
IndustrySoftware - Application
Market Cap12.10MEPS (ttm)3.00
P/E1.53EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y38.27%
P/S3.72EPS next 5Y-
P/B0.24EPS Q/Q833.42%
Dividend-Sales Q/Q-59.60%
Insider Own10.10%Inst Own2.70%
Insider Trans0.00%Inst Trans-
Short Float0.17%EarningsNov 29/a
Analyst Recom-Target Price-
Avg Volume110.78K52W Range2.11 - 24.88
Next Technology Holding, Inc. engages in the provision of software development services to the customers and bitcoin acquisition. The company was founded on March 28, 2019 and is headquartered in Shenzhen, China.
1234567891014